Sanofi-aventis has a significant presence in India and has 1,800 employees.
Sanofi-aventis on Monday said it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US biotechnology firm.